Legence Corp. (LGN) registers securities for 2025 omnibus incentive plan
Rhea-AI Filing Summary
Legence Corp. filed a Form S-8 registration statement to register securities for issuance under the Legence Corp. 2025 Omnibus Incentive Plan. The filing incorporates by reference the company’s existing and future Exchange Act reports so that ongoing disclosures automatically update this registration. It describes how the company’s charter and bylaws, together with Delaware law, limit personal monetary liability of directors and officers and allow broad indemnification and advancement of expenses, supplemented by directors’ and officers’ insurance and separate indemnification agreements. The document also lists key exhibits, including the amended and restated certificate of incorporation, bylaws, the 2025 Omnibus Incentive Plan itself, legal opinions, auditor consents, and the filing fee table, and is signed by the chief executive officer and other senior officers and directors.
Positive
- None.
Negative
- None.
FAQ
What did Legence Corp. (LGN) file in this Form S-8?
Legence Corp. filed a Form S-8 registration statement to register securities that may be issued under the Legence Corp. 2025 Omnibus Incentive Plan. The filing also incorporates certain current and future SEC reports by reference.
What is the purpose of the Legence Corp. 2025 Omnibus Incentive Plan?
The filing identifies the Legence Corp. 2025 Omnibus Incentive Plan as the plan covered by this registration statement. Detailed information about the plan is delivered separately to participants and is incorporated by reference rather than described in this document.
How does Legence Corp. describe indemnification of its directors and officers?
The document explains that Legence Corp.’s amended and restated certificate of incorporation and amended and restated bylaws provide for limitation of monetary liability and broad indemnification and advancement of expenses for directors and officers to the fullest extent permitted by the Delaware General Corporation Law.
Does Legence Corp. maintain insurance for its directors and officers?
Yes. The filing states that Legence Corp. has obtained and intends to maintain directors’ and officers’ liability insurance covering its directors, officers and some employees for specified liabilities.
What other protections are provided to individuals administering the 2025 Plan?
The filing notes that members of the committee administering the 2025 Omnibus Incentive Plan, and certain subcommittees, are not personally liable for good-faith actions or determinations under the plan and are to be indemnified and held harmless by Legence Corp. to the maximum extent permitted by law.
Which key exhibits are included or incorporated in this Form S-8 for Legence Corp.?
Listed exhibits include the amended and restated certificate of incorporation, amended and restated bylaws, the Legence Corp. 2025 Omnibus Incentive Plan, a legal opinion from Kirkland & Ellis LLP, consents from Deloitte & Touche LLP, a consent from Kirkland & Ellis LLP, a power of attorney, and the filing fee table.
Who signed the Legence Corp. Form S-8 registration statement?
The registration statement is signed on behalf of Legence Corp. by Chief Executive Officer Jeffrey Sprau and also bears signatures from the Chief Financial Officer, Chief Accounting Officer, and several directors, with a power of attorney designating certain officers to sign amendments.